Literature DB >> 19289141

Liver cancer mortality among male prison inmates in Texas, 1992-2003.

Amy J Harzke1, Jacques G Baillargeon, Karen J Goodman, Sandi L Pruitt.   

Abstract

OBJECTIVES: Prevalence estimates for several liver cancer risk factors-hepatitis C, hepatitis B, and history of alcohol abuse-are substantially higher in U.S. prison populations than in the general population. However, liver cancer mortality data from these populations are lacking. The primary aims of this study were to examine trends in liver cancer mortality rates from 1992 to 2003 among male prisoners in the Texas Department of Criminal Justice (TDCJ) and to compare these rates to general population rates.
METHODS: TDCJ data on male decedents (N=4026) were linked with Texas Vital Statistics multiple-cause-of-death data. Crude average annual liver cancer death rates, average annual percent changes, and standardized mortality ratios were estimated.
RESULTS: Crude liver cancer death rates increased by an average annual 6.1% among male prisoners, which was considerably higher than the average annual percent change among similarly aged males in Texas (2.0%) and the U.S. (2.9%). The number of liver cancer deaths among male prisoners was 4.7 (4.0-5.6) and 6.3 (5.3-7.5) times higher than the expected number of deaths estimated using age-specific rates from these reference populations.
CONCLUSIONS: From 1992 to 2003, liver cancer death rates and rate increases were elevated among Texas male prisoners. Findings support previous recommendations for targeted prevention, screening, and treatment of liver cancer risk factors in prison populations.

Entities:  

Mesh:

Year:  2009        PMID: 19289141      PMCID: PMC2879635          DOI: 10.1016/j.ypmed.2009.03.011

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  25 in total

1.  Aging prisoners stressing health care system.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

2.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  A simple method to calculate the confidence interval of a standardized mortality ratio (SMR)

Authors:  K Ulm
Journal:  Am J Epidemiol       Date:  1990-02       Impact factor: 4.897

4.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

5.  Hepatitis B vaccination of inmates in correctional facilities--Texas, 2000-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-08-06       Impact factor: 17.586

6.  The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; S Patricia Chou; Mary C Dufour; Roger P Pickering
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

7.  Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

Authors:  Joshua A Salomon; Milton C Weinstein; James K Hammitt; Sue J Goldie
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

8.  Prevalence and correlates of DSM-IV and ICD-10 alcohol dependence: 1990 US National Alcohol Survey.

Authors:  R Caetano; T W Tam
Journal:  Alcohol Alcohol       Date:  1995-03       Impact factor: 2.826

9.  The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

Authors:  Hashem B El-Serag; Jessica A Davila; Nancy J Petersen; Katherine A McGlynn
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.

Authors:  Liza Solomon; Colin Flynn; Kelly Muck; John Vertefeuille
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

View more
  2 in total

1.  Cancer prevalence, incidence and mortality in people who experience incarceration in Ontario, Canada: A population-based retrospective cohort study.

Authors:  Fiona G Kouyoumdjian; Lucie Pivnick; Kathryn E McIsaac; Andrew S Wilton; Aisha Lofters; Stephen W Hwang
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

Review 2.  Disparities in cancer prevalence, incidence, and mortality for incarcerated and formerly incarcerated patients: A scoping review.

Authors:  Christopher R Manz; Varshini S Odayar; Deborah Schrag
Journal:  Cancer Med       Date:  2021-09-03       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.